RxDoctor Payments Data

Aswin Kansakar

Internal Medicine · Monticello, INNPI 1467975573

Payments from drug & device makers

$2,206in general payments, 2019–2025

Across 118 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$409
  • Novo Nordisk$262
  • Amgen$225
  • AstraZeneca$180
  • Novartis$172
  • AbbVie$137
  • plus $821 from 21 others

What the payments were for

  • Food & beverage$2,206100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,206 in reported general payments places this provider in the 85th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$66,315
JardianceEmpagliflozin63$56,210
OzempicSemaglutide32$30,561
TrulicityDulaglutide21$23,845
FarxigaDapagliflozin Propanediol20$22,124
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,612
Spiriva RespimatTiotropium Bromide14$7,390
LinzessLinaclotide13$6,637
Breo ElliptaFluticasone/Vilanterol15$5,802
EliquisApixaban16$5,259
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,457
Albuterol Sulfate HfaAlbuterol Sulfate60$1,569
Atorvastatin Calcium233$1,413
Duloxetine Hcl57$1,019
Gabapentin57$993

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$409$90,16183 claims
Boehringer IngelheimJardiance, Spiriva Respimat$39$63,59977 claims
AstraZenecaFarxiga, Breztri Aerosphere$180$33,73638 claims
Novo NordiskOzempic$262$30,56132 claims
AbbVieLinzess, Synthroid$137$7,43535 claims
GSKBreo Ellipta$64$5,80215 claims
PfizerEliquis$60$5,25916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,747 internal medicine providers in Indiana.

Other internal medicine in Monticello

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →